Common Stock, Value, Issued of Odyssey Health, Inc. from 31 Jul 2014 to 31 Jan 2026

Taxonomy & unit: us-gaap: USD
Description: Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary: Odyssey Health, Inc. quarterly Common Stock, Value, Issued in USD history and change rate from 31 Jul 2014 to 31 Jan 2026.
Odyssey Health, Inc. Common Stock, Value, Issued for the quarter ending 31 Jan 2026 was $99,854, a 3.3% increase year-over-year.
Source SEC data: View on sec.gov

Common Stock, Value, Issued, Quarterly (USD)

Common Stock, Value, Issued, YoY Quarterly Change (%)

Odyssey Health, Inc. Quarterly Common Stock, Value, Issued (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$99,854	+$3,144	+3.3%	31 Jan 2026	10-Q	12 Mar 2026	2026	Q2
Q3 2025	$99,854	+$3,144	+3.3%	31 Oct 2025	10-Q	11 Dec 2025	2026	Q1
Q2 2025	$96,710	$0	0%	31 Jul 2025	10-Q	12 Mar 2026	2026	Q2
Q1 2025	$96,710	+$350	+0.36%	30 Apr 2025	10-Q	13 Jun 2025	2025	Q3
Q4 2024	$96,710	+$2,276	+2.4%	31 Jan 2025	10-Q	14 Mar 2025	2025	Q2
Q3 2024	$96,710	+$14,976	+18%	31 Oct 2024	10-Q	16 Dec 2024	2025	Q1
Q2 2024	$96,710	+$17,642	+22%	31 Jul 2024	10-K	29 Oct 2025	2025	FY
Q1 2024	$96,360	+$18,252	+23%	30 Apr 2024	10-Q	14 Jun 2024	2024	Q3
Q4 2023	$94,434	+$18,626	+25%	31 Jan 2024	10-Q	22 Mar 2024	2024	Q2
Q3 2023	$81,734	+$9,739	+14%	31 Oct 2023	10-Q	15 Dec 2023	2024	Q1
Q2 2023	$79,068	+$1,207	+1.6%	31 Jul 2023	10-K	13 Nov 2024	2024	FY
Q1 2023	$78,108	-$4,770	-5.8%	30 Apr 2023	10-Q	14 Jun 2023	2023	Q3
Q4 2022	$75,808	-$6,899	-8.3%	31 Jan 2023	10-Q	17 Mar 2023	2023	Q2
Q3 2022	$71,995	-$19,021	-21%	31 Oct 2022	10-Q	14 Dec 2022	2023	Q1
Q2 2022	$77,861	-$9,330	-11%	31 Jul 2022	10-K	30 Oct 2023	2023	FY
Q1 2022	$82,878	-$18,661	-18%	30 Apr 2022	10-Q	14 Jun 2022	2022	Q3
Q4 2021	$82,707	-$8,903	-9.7%	31 Jan 2022	10-Q	15 Mar 2022	2022	Q2
Q3 2021	$91,016	+$446	+0.49%	31 Oct 2021	10-Q	10 Dec 2021	2022	Q1
Q2 2021	$87,191	-$1,369	-1.5%	31 Jul 2021	10-K	31 Oct 2022	2022	FY
Q1 2021	$101,539	+$14,349	+16%	30 Apr 2021	10-Q	21 Jun 2021	2021	Q3
Q4 2020	$91,610	+$4,420	+5.1%	31 Jan 2021	10-Q	11 Mar 2021	2021	Q2
Q3 2020	$90,570	+$3,580	+4.1%	31 Oct 2020	10-Q	11 Dec 2020	2020	Q1
Q2 2020	$88,560	+$1,570	+1.8%	31 Jul 2020	10-K	29 Oct 2021	2021	FY
Q1 2020	$87,190	+$18,445	+27%	30 Apr 2020	10-Q/A	13 Nov 2020	2020	Q3
Q4 2019	$87,190	+$18,545	+27%	31 Jan 2020	10-Q/A	13 Nov 2020	2020	Q2
Q3 2019	$86,990	+$25,576	+42%	31 Oct 2019	10-Q/A	13 Nov 2020	2020	Q1
Q2 2019	$86,990	+$25,576	+42%	31 Jul 2019	10-K	16 Nov 2020	2021	FY
Q1 2019	$68,745	-$51,095	-43%	30 Apr 2019	10-Q	07 Jun 2019	2019	Q3
Q4 2018	$68,645	-$51,195	-43%	31 Jan 2019	10-Q	14 Mar 2019	2019	Q2
Q3 2018	$61,414	-$53,426	-47%	31 Oct 2018	10-Q	13 Mar 2019	2019	Q1
Q2 2018	$61,414	-$53,426	-47%	31 Jul 2018	10-K/A	13 Nov 2020	2019	FY
Q1 2018	$119,840	+$5,000	+4.4%	30 Apr 2018	10-Q	07 Aug 2018	2018	Q3
Q4 2017	$119,840	+$5,000	+4.4%	31 Jan 2018	10-Q	30 May 2018	2018	Q2
Q3 2017	$114,840	+$90	+0.08%	31 Oct 2017	10-Q	20 Dec 2017	2018	Q1
Q2 2017	$114,840	+$90	+0.08%	31 Jul 2017	10-K	12 Dec 2018	2018	FY
Q1 2017	$114,840	+$90	+0.08%	30 Apr 2017	10-Q	21 Jun 2017	2017	Q3
Q4 2016	$114,840	+$90	+0.08%	31 Jan 2017	10-Q	23 Mar 2017	2017	Q2
Q3 2016	$114,750	$0	0%	31 Oct 2016	10-Q	20 Dec 2016	2017	Q1
Q2 2016	$114,750	$0	0%	31 Jul 2016	10-K	14 Nov 2017	2017	FY
Q1 2016	$114,750			30 Apr 2016	10-Q	16 Jun 2016	2016	Q3
Q4 2015	$114,750			31 Jan 2016	10-Q	15 Mar 2016	2016	Q2
Q3 2015	$114,750			31 Oct 2015	10-Q	22 Dec 2015	2016	Q1
Q2 2015	$114,750	$0	0%	31 Jul 2015	10-K	02 Nov 2016	2016	FY
Q2 2014	$114,750			31 Jul 2014	10-K	01 Dec 2015	2015	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.